US Patent 7312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1)
Patent 7312066 was granted and assigned to New York University Press on December, 2007 by the United States Patent and Trademark Office.
All edits
The present invention relates to isolated human and rat nucleic acid molecules encoding a protein or polypeptide that modulates transcriptional activation in a cell with or without collaboration with a nuclear hormone receptor transcriptional co-activator. The present invention also relates to the proteins or polypeptides encoded by those nucleic acid molecules, and antibodies against such proteins or polypeptides. The present invention also relates to a variety of uses for the nucleic acid molecules, proteins or polypeptides, and the related antibodies of the present invention, including methods of: regulating cellular proliferation, differentiation, and development; modulating the activity of a transcriptional co-activator complex and a transcription factor in cells; regulating hormone receptor activity and endocrine function in cells; and treating diabetes and insulin resistance in a subject.
US Patent 07312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1) US Patent 7312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1)
US Patent 07312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1)
Find more entities like US Patent 7312066 Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1)
